Advertisement Pharmaceutical Business review - Page 4382 of 5288 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 3, 2026

Novartis signs deal with Alteogen for drug delivery

Novartis has signed an agreement with Alteogen that could be worth up to $3.22bn for the development and commercialisation of subcutaneous drug formulations using Alteogen’s ALT-B4 technology.

Continue
The deal allows Novartis options for exclusive global rights to develop subcutaneous versions of products using ALT-B4. Credit: Michael Derrer Fuchs/Shutterstock.com.
September 3, 2026

Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule

The licensed VHH antibody molecule originates from RenNano, Biocytogen’s technology designed to identify fully human VHH antibodies. Credit: Anamaria Mejia / Shutterstock.com.
September 2, 2026

Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology

Aitia uses its technology platform to discover new drug targets and biomarkers. Credit: PeopleImages / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Takeda and Weave Bio collaborate on AI-driven automation in drug development
  2. PharmaEssentia’s Besremi receives FDA approval for ET
  3. Kazia closes oversubscribed offering to fund paxalisib’s clinical development
  4. Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
  5. FDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911

PRESS RELEASES

Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography